{"id":234,"date":"2014-12-20T09:59:53","date_gmt":"2014-12-20T09:59:53","guid":{"rendered":"https:\/\/delveinsightblog.wordpress.com\/?p=234"},"modified":"2021-07-24T12:56:23","modified_gmt":"2021-07-24T07:26:23","slug":"delveinsights-genitourinary-sex-hormones-based-gene-therapy-reports","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/delveinsights-genitourinary-sex-hormones-based-gene-therapy-reports","title":{"rendered":"DelveInsight\u2019s Genitourinary Sex hormones based Gene Therapy Reports"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_76 counter-hierarchy ez-toc-counter ez-toc-white ez-toc-container-direction\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<label for=\"ez-toc-cssicon-toggle-item-6a00d817c6cc7\" class=\"ez-toc-cssicon-toggle-label\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/label><input type=\"checkbox\"  id=\"ez-toc-cssicon-toggle-item-6a00d817c6cc7\"  aria-label=\"Toggle\" \/><nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.delveinsight.com\/blog\/delveinsights-genitourinary-sex-hormones-based-gene-therapy-reports\/#Gene_Therapys_buzz_in_the_field_of_Genitourinary_disorders\" >Gene Therapy\u2019s buzz in the field of Genitourinary disorders!<\/a><ul class='ez-toc-list-level-4' ><li class='ez-toc-heading-level-4'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.delveinsight.com\/blog\/delveinsights-genitourinary-sex-hormones-based-gene-therapy-reports\/#About_Genitourinary_disorders\" >About Genitourinary disorders<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.delveinsight.com\/blog\/delveinsights-genitourinary-sex-hormones-based-gene-therapy-reports\/#Gene_Therapy_Role_in_Genitourinary_diseases\" >Gene Therapy: Role in Genitourinary diseases<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.delveinsight.com\/blog\/delveinsights-genitourinary-sex-hormones-based-gene-therapy-reports\/#Gene_Therapy_The_Market_Scenario\" >Gene Therapy: The Market Scenario<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.delveinsight.com\/blog\/delveinsights-genitourinary-sex-hormones-based-gene-therapy-reports\/#DelveInsights_Gene_Therapy_Reports\" >DelveInsight\u2019s Gene Therapy Reports<\/a><\/li><\/ul><\/nav><\/div>\n<blockquote>\n<h3 style=\"text-align: center;\"><span class=\"ez-toc-section\" id=\"Gene_Therapys_buzz_in_the_field_of_Genitourinary_disorders\"><\/span><span style=\"color: #ff0000;\">Gene Therapy\u2019s buzz in the field of Genitourinary disorders!<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<\/blockquote>\n<h4><span class=\"ez-toc-section\" id=\"About_Genitourinary_disorders\"><\/span><span style=\"color: #800000;\">About Genitourinary disorders<\/span><span class=\"ez-toc-section-end\"><\/span><\/h4>\n<p style=\"text-align: justify;\"><span style=\"color: #333399;\">Genitourinary disorders study of diseases of the prostate, bladder, kidney, testis, and related organs such as the penis, retro peritoneum, and adrenal glands. Genitourinary disorders are a major health problem that seriously affects the quality of life of patients and their partners. There are more patients with bladder dysfunctions related to its primary function of urine storage and voiding than cancer. These include: lower urinary tract symptoms (LUTS), interstitial cystitis (IC), overactive bladder (OAB) and urinary incontinence (UI) etc. Another urological problem is erectile dysfunction (ED). Although not life threatening by itself, ED and bladder dysfunction are a strong indicator of other life threatening diseases such as coronary artery disease and cardiovascular disease.<\/span><\/p>\n<h3 style=\"text-align: justify;\"><span class=\"ez-toc-section\" id=\"Gene_Therapy_Role_in_Genitourinary_diseases\"><\/span><span style=\"color: #800000;\">Gene Therapy: Role in Genitourinary diseases<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span style=\"color: #333399;\">Most current therapies for these genitourinary conditions are palliative rather than therapeutic. Gene therapy however, may provide a way to cure the disease. The application of gene therapy in the field of genitourinary disorders is not limited to cancer therapy but is also being evaluated for non-cancer related bladder dysfunctions as well as erectile dysfunction (ED).<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"color: #333399;\">Maxi-K therapy is a unique, locally administrated gene-transfer technology to treat erectile dysfunction (ED). The safety and the restorative effects of the treatment have been shown by data from participants in a clinical trial.<\/span><\/p>\n<h3><span class=\"ez-toc-section\" id=\"Gene_Therapy_The_Market_Scenario\"><\/span><span style=\"color: #800000;\">Gene Therapy: The Market Scenario<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span style=\"color: #333399;\">A growing number of partnership between Big Pharma companies in drug development like between Novartis and Quark are driving the new gene therapy research in the field of urology. Currently Ion channel Innovation is working to discover and develop novel treatments for genitourinary disorders. Maxi-K is the lead compound being developed under the field of genitourinary disorders. Only two clinical trials are listed for urological conditions unrelated to cancer. One is the clinical trial for ED and the other is a trial for overactive bladder syndrome. Both trials used plasmid DNA carrying the calcium activated potassium channel. The results of the clinical trial for ED indicate the safety of this delivery system. This has led to an increase in the global market opportunities for gene therapy with more companies focusing in this field.<\/span><\/p>\n<h3><span class=\"ez-toc-section\" id=\"DelveInsights_Gene_Therapy_Reports\"><\/span><span style=\"color: #800000;\">DelveInsight\u2019s Gene Therapy Reports<\/span><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p style=\"text-align: justify;\"><span style=\"color: #333399;\"><strong>DelveInsight\u2019s Gene Therapy Reports<\/strong> cover the entire gene therapy market insights for genitourinary disorders including technology assessments, licensing opportunities, collaborations, market trends, pipeline coverage and competitive landscape. The report essentially provides DelveInsight\u2019s proprietary market and pipeline analytics which identifies the front runners in this therapeutic area. It also identifies the potential market movers and future regulatory landscape.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gene Therapy\u2019s buzz in the field of Genitourinary disorders! About Genitourinary disorders Genitourinary disorders study of diseases of the prostate, bladder, kidney, testis, and related organs such as the penis, retro peritoneum, and adrenal glands. Genitourinary disorders are a major health problem that seriously affects the quality of life of patients and their partners. There [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[173,180,209,235,258,266,336,356,364,386,445,479,558,589],"industry":[17225],"therapeutic_areas":[17235,17230],"class_list":["post-234","post","type-post","status-publish","format-standard","hentry","category-articles","tag-collaborations","tag-competitive-landscape","tag-delveinsights-gene-therapy-reports","tag-erectile-dysfunction-ed","tag-gene-therapy","tag-genitourinary-disorders","tag-interstitial-cystitis-ic","tag-licensing-opportunities","tag-lower-urinary-tract-symptoms-luts","tag-market-trends","tag-overactive-bladder-oab","tag-pipeline-coverage","tag-technology-assessments","tag-urinary-incontinence-ui","industry-pharmaceutical","therapeutic_areas-cell-and-gene-therapy","therapeutic_areas-genito-urinary-system-and-sex-hormones"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Genitourinary Sex hormones based Gene Therapy Market Reports<\/title>\n<meta name=\"description\" content=\"Genitourinary disorders study of diseases of the prostate, bladder, kidney, testis, and related organs such as the penis, retro peritoneum..\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/delveinsights-genitourinary-sex-hormones-based-gene-therapy-reports\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Genitourinary Sex hormones based Gene Therapy Market Reports\" \/>\n<meta property=\"og:description\" content=\"Genitourinary disorders study of diseases of the prostate, bladder, kidney, testis, and related organs such as the penis, retro peritoneum..\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/delveinsights-genitourinary-sex-hormones-based-gene-therapy-reports\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-12-20T09:59:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-24T07:26:23+00:00\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Genitourinary Sex hormones based Gene Therapy Market Reports","description":"Genitourinary disorders study of diseases of the prostate, bladder, kidney, testis, and related organs such as the penis, retro peritoneum..","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/delveinsights-genitourinary-sex-hormones-based-gene-therapy-reports","og_locale":"en_US","og_type":"article","og_title":"Genitourinary Sex hormones based Gene Therapy Market Reports","og_description":"Genitourinary disorders study of diseases of the prostate, bladder, kidney, testis, and related organs such as the penis, retro peritoneum..","og_url":"https:\/\/www.delveinsight.com\/blog\/delveinsights-genitourinary-sex-hormones-based-gene-therapy-reports","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2014-12-20T09:59:53+00:00","article_modified_time":"2021-07-24T07:26:23+00:00","author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/delveinsights-genitourinary-sex-hormones-based-gene-therapy-reports","url":"https:\/\/www.delveinsight.com\/blog\/delveinsights-genitourinary-sex-hormones-based-gene-therapy-reports","name":"Genitourinary Sex hormones based Gene Therapy Market Reports","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"datePublished":"2014-12-20T09:59:53+00:00","dateModified":"2021-07-24T07:26:23+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"Genitourinary disorders study of diseases of the prostate, bladder, kidney, testis, and related organs such as the penis, retro peritoneum..","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/delveinsights-genitourinary-sex-hormones-based-gene-therapy-reports"]}]},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":null,"coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">collaborations<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Competitive landscape<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">DelveInsight&#039;s Gene Therapy Reports<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">erectile dysfunction (ED)<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Gene therapy<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">genitourinary disorders<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">interstitial cystitis (IC)<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">licensing opportunities<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">lower urinary tract symptoms (LUTS)<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">market trends<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">overactive bladder (OAB)<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Pipeline coverage<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">technology assessments<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">urinary incontinence (UI)<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">collaborations<\/span>","<span class=\"advgb-post-tax-term\">Competitive landscape<\/span>","<span class=\"advgb-post-tax-term\">DelveInsight&#039;s Gene Therapy Reports<\/span>","<span class=\"advgb-post-tax-term\">erectile dysfunction (ED)<\/span>","<span class=\"advgb-post-tax-term\">Gene therapy<\/span>","<span class=\"advgb-post-tax-term\">genitourinary disorders<\/span>","<span class=\"advgb-post-tax-term\">interstitial cystitis (IC)<\/span>","<span class=\"advgb-post-tax-term\">licensing opportunities<\/span>","<span class=\"advgb-post-tax-term\">lower urinary tract symptoms (LUTS)<\/span>","<span class=\"advgb-post-tax-term\">market trends<\/span>","<span class=\"advgb-post-tax-term\">overactive bladder (OAB)<\/span>","<span class=\"advgb-post-tax-term\">Pipeline coverage<\/span>","<span class=\"advgb-post-tax-term\">technology assessments<\/span>","<span class=\"advgb-post-tax-term\">urinary incontinence (UI)<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 11 years ago","modified":"Updated 5 years ago"},"absolute_dates":{"created":"Posted on Dec 20, 2014","modified":"Updated on Jul 24, 2021"},"absolute_dates_time":{"created":"Posted on Dec 20, 2014 9:59 am","modified":"Updated on Jul 24, 2021 12:56 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/234","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=234"}],"version-history":[{"count":0,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/234\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=234"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=234"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=234"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=234"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}